Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1220 participants
OBSERVATIONAL
2006-01-01
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Doxycycline in Therapy of Erythema Migrans
NCT01475708
Inflammatory Responses in Solitary and Multiple Erythema Migrans
NCT03980015
Clinical Manifestations and Long-Term Outcome in Early Lyme Neuroborreliosis
NCT04653558
Patient's Pretreatment Expectations About Post-Lyme Symptoms
NCT03462329
Inflammatory Mediators in Erythema Migrans
NCT03956212
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
elderly patients
Antibiotics
Patients were treated with antibiotics for Lyme disease.
middle-aged patients
Antibiotics
Patients were treated with antibiotics for Lyme disease.
controls
no intervention
controls were not given antibiotics
young patients
Antibiotics
Patients were treated with antibiotics for Lyme disease.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Antibiotics
Patients were treated with antibiotics for Lyme disease.
no intervention
controls were not given antibiotics
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* immunocompromised
* taking antibiotic with antiborrelial activity within 10 days
* received \<10 days of antibiotic therapy for erythema migrans
* had an intercurrent episode of Lyme borreliosis during follow-up
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Medical Centre Ljubljana
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Daša Stupica
MD, PhD
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EM-elderly
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.